Tekla Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-131,183
| Closed | -$2.13M | – | 194 |
|
|
2021
Q1 | $2.13M | Hold |
131,183
| – | – | 0.07% | 160 |
|
|
2020
Q4 | $2.78M | Hold |
131,183
| – | – | 0.1% | 145 |
|
|
2020
Q3 | $1.94M | Hold |
131,183
| – | – | 0.07% | 157 |
|
|
2020
Q2 | $1.93M | Hold |
131,183
| – | – | 0.07% | 163 |
|
|
2020
Q1 | $1.54M | Buy |
131,183
+71,341
| +119% | +$837K | 0.07% | 150 |
|
|
2019
Q4 | $1.41M | Buy |
+59,842
| New | +$1.41M | 0.05% | 168 |
|
|
2016
Q3 | – | Sell |
-492,303
| Closed | -$8.89M | – | 143 |
|
|
2016
Q2 | $8.89M | Buy |
492,303
+273,303
| +125% | +$4.93M | 0.36% | 62 |
|
|
2016
Q1 | $4.16M | Hold |
219,000
| – | – | 0.18% | 95 |
|
|
2015
Q4 | $5.85M | Hold |
219,000
| – | – | 0.21% | 83 |
|
|
2015
Q3 | $5.34M | Sell |
219,000
-217,970
| -50% | -$5.32M | 0.19% | 86 |
|
|
2015
Q2 | $13.6M | Sell |
436,970
-436,970
| -50% | -$13.6M | 0.49% | 42 |
|
|
2015
Q1 | $12.7M | Hold |
873,940
| – | – | 0.5% | 46 |
|
|
2014
Q4 | $8.79M | Hold |
873,940
| – | – | 0.41% | 56 |
|
|
2014
Q3 | $7.28M | Hold |
873,940
| – | – | 0.34% | 61 |
|
|
2014
Q2 | $10.8M | Buy |
873,940
+177,343
| +25% | +$2.18M | 0.99% | 27 |
|
|
2014
Q1 | $9.69M | Buy |
+696,597
| New | +$9.69M | 0.97% | 28 |
|